Update from the Centers for Disease Control and Prevention on COVID-19 Booster Shots
The OIF’s Medical Advisory Council recommends following the Centers for Disease Control and Prevention (CDC) COVID-19 guidelines. The COVID-19 Toolkit is an ever-evolving resource, it is our goal to provide community members with the most up to date medically verified information. The Centers for Disease Control and Prevention released the CDC Statement on ACIP Booster Recommendations regarding the Pfizer-BioNTech COVID-19 booster shot recommendations on Friday, September 24th, 2021.
people 65 years and older and residents in long-term care settings should receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series,
people aged 50–64 years with underlying medical conditionsshould receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine atleast 6 months after their Pfizer-BioNTech primary series,
people aged 18–49 years with underlying medical conditionsmay receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series, based on their individual benefits and risks, and
people aged 18-64 years who are at increased risk for COVID-19 exposure and transmission because of occupational or institutional setting may receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series, based on their individual benefits and risks.
Osteogenesis Imperfecta (OI), while primarily known as a bone disease leading to frequent fractures, is at its core a genetic defect in collagen manufacture, assembly, and/or quantity. While collagen is important in the normal growth and mineralization of bone, collagen also makes up a large portion of the connective tissue of the lungs. Individuals with OI have underlying lung disease due to these collagen defects and, in fact, respiratory failure is the major cause of death in individuals with OI. Therefore, it is highly likely that individuals with OI who develop COVID-19 will get more severe disease than the general population and should therefore be included in the vaccine prioritization group that includes those with chronic lung disease such as COPD. (Source Resource: Sample Vaccine Letter)
Resource: Research on Pulmonary Health and OI
The connection between chronic lung disease and osteogenesis imperfecta has been shown in multiple studies. You can share the following articles with your doctor and relevant parties.
We had so much fun this summer during the kids zoom social at this year’s virtual conference! What better way to bring in the fall season than with a virtual costume party?
Join us Friday October 29th at 6pm EST for the Kids Social Zoom: Virtual Costume Party. Your child will have the opportunity to socialize with old friends and make new ones, play Halloween-themed ice breaker games, and so much more!
Happy Grandparents Day! Grandparents play an important role in the lives of their grandchildren. We are grateful to all of the wonderful grandparents in the OI community for the love and support they provide. ?
Don’t Miss Your Chance to Make an IMPACT on the Future of OI Research!
The IMPACT Survey is the first-ever international survey aimed at capturing and quantifying the real impact OI has on people’s lives. The results from this survey will be used to enable better healthcare services for both children and adults and to support availability of potential future treatments for OI. The Impact Survey will close at the end of this month.
If you have OI, or are a parent/caregiver of a child with OI, WE NEED TO HEAR FROM YOU!
The OI Foundation has completed the initial phase of the OIF’s diversity, equity, and inclusion project. This first phase was designed to assess the OIF’s programs, activities, and business structures. With the help of diversity, equity and inclusion professional, Chaz Kellem, we conducted an internal review of our programs and services to determine how we can be more inclusive as a Foundation in order to support the entire OI community.
Some of the goals of the OIF’s diversity, equity, and inclusion project are:
■ To evolve our OI community to reflect the demographics of the locations in which we serve
■ To make sure all members of the OI community are fully aware of and can access the full scope of OIF resources and services
■ To ensure every OI community member, staff member, and board member feels included and fully engaged
The next phase of this project will consist of incorporating OI Foundation staff training and development, business recommendations, board development, community engagement practices, and more. Please stay tuned for updates on this important project!
More research into OI is being done than ever before, and the complex findings and breakthroughs can be hard to understand. On Wishbone Day (May 6), the OIF launched an educational series to highlight and explain the work of the Brittle Bone Disorders Consortium (BBDC).
The second video in this series, Women’s Health and Pregnancy, was held on June 24 with Deborah Krakow, MD (OIF MAC member and Professor and Chair of Obstetrics and Gynecology at UCLA) and Tracy Hart (OIF CEO).
In both talks, the researchers emphasized the importance of the BBDC, how they approach researching OI, and the big questions they seek to answer. To view session recordings, please visit the OIF website (Video Resources page) or OIF YouTube channel.